Trials / Conditions / Rash Due to Epidermal Growth Factor Receptor Inhibitors
Rash Due to Epidermal Growth Factor Receptor Inhibitors
3 registered clinical trials studyying Rash Due to Epidermal Growth Factor Receptor Inhibitors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients W NCT07469488 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 4 |
| Completed | Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cance NCT02239731 | Vyne Therapeutics Inc. | Phase 2 |
| Completed | A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI NCT01763307 | Hadassah Medical Organization | Phase 2 |